Navigation Links
Bio-Tech Firm PathSensors Enters Fast-Growing Chinese Pathogen Detection Market
Date:8/21/2017

Baltimore biotech firm, PathSensors, Inc., announced today it has partnered with a leading Chinese bio security firm, to bring its proprietary CANARY pathogen detection technology and high throughput testing solutions to the Chinese market. As part of the relationship, the Chinese firm has purchased an undisclosed number of PathSensors’ Zephyr pathogen detection instruments and will act as a distributor to further spread the technology within China.

The Zephyr allows customers to detect a wide range of toxins, bacteria and other pathogens in minutes, thanks to PathSensors’ CANARY® (Cellular Analysis and Notification of Antigen Risks and Yields) biosensor technology. The Zephyr is ideal for applications such as bio-security, food safety, environmental monitoring, first responders, and plant safety. PathSensors assays can detect pathogens in minutes, at levels of sensitivity far superior to alternative diagnostic technologies.

Ted Olsen, CEO of PathSensors, commented, “China is a leading market for advanced pathogen detection solutions. Our partner has a proven track record in bio security applications and we look forward to working with them to introduce Chinese customers to the benefits of CANARY technology.”

About PathSensors, Inc.
PathSensors is a leading biotechnology solutions and environmental testing company. PathSensors provides high speed, highly sensitive pathogen and threat detection solutions for the defense, homeland security, public health, medical countermeasures, mail room screening, first responder, food processing and agricultural sectors. For more information, visit http://www.pathsensors.com.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14612775.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Bio-Tech Firm PathSensors Launches High-Throughput Diagnostics for Plant Safety at 2017 American Phytopathological Society (APS) Annual Conference
2. Bio-Techne To Present At The Leerink Partners 6th Annual Global Healthcare Conference
3. Bio-Techne To Host Conference Call On February 7, 2017 To Announce Second Quarter Financial Results
4. Instrument Business Outlook Names Bio-Techne 2016 Company of the Year
5. COPD Biomarker Qualification Consortium Partners with Bio-Techne to Identify COPD Indicator
6. Global Bio-Tech Flavor Market is Expected to Reach US$ 2,092.2 Mn by 2024 - Persistence Market Research
7. Lotus Bio-Technology Reveals Financial Position of Strategic Partner, as Relationship Strengthens with the Creation of New CBD Product Line
8. Bio-Techne Releases Second Quarter Fiscal 2016 Results
9. Bio-Techne To Host Conference Call On February 2, 2016 To Announce Second Quarter Financial Results
10. Bio-Techne Announces Agreement To Acquire CyVek
11. Bio-Techne Declares Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2020)... Del. (PRWEB) , ... August 29, 2020 , ... ... a new Animal Nutrition manufacturing capability in Wuxi, China. The new plant operation ... global quality standards and advanced technology. , “This facility will improve the ...
(Date:8/15/2020)... SCOTTSDALE, Ariz. (PRWEB) , ... August 13, 2020 ... ... 4254 on its annual Inc. 5000 list, the most prestigious ranking of the ... successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... is making available for free its new white paper – Simulated Transport ... testing into today’s biologics licensing application (BLA). In response, Modality Solutions shares ...
(Date:8/7/2020)... WOODLANDS, Texas (PRWEB) , ... August 06, 2020 ... ... therapy and DNA vaccine industries, announces it has closed on the purchase of ... Technology Park in Conroe, TX and includes over 21 acres in the initial ...
Breaking Biology Technology:
(Date:7/31/2020)... FRANCISCO (PRWEB) , ... July 30, 2020 , ... ... maturing prescription digital therapeutics product portfolio with a near term focus on Type ... biotech and pharma commercialization experience across multiple therapeutic areas and classes. As Chief ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... effectiveness of the Invictus Medical Neoasis™ active noise control device to attenuate typical ... that the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and ...
(Date:7/10/2020)... (PRWEB) , ... July 08, 2020 , ... ... on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 ... a comparability study, but what is the most effective way to complete one? ...
Breaking Biology News(10 mins):